Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein S36 pseudogene 5 (MRPS36P5) is classified as a *processed pseudogene*, meaning it is a DNA sequence similar to a functional gene (in this case, one encoding a mitochondrial ribosomal protein from the S36 family), but it does not produce a functional protein due to disruptive mutations or lack of regulatory elements[2][3][6]. This locus is listed in gene and protein databases (e.g., HGNC ID: 29775, NCBI Gene ID: 347703, Ensembl: ENSG00000257927)[2][3][6]. While pseudogenes as a class can sometimes exert regulatory effects at the RNA level (such as acting as microRNA decoys or sources of small interfering RNAs[4]), there is no evidence from available sources that MRPS36P5 has any such regulatory function or clinical relevance. It does not encode a protein, nor is it a receptor, enzyme, transporter, or typical drug target[3][4][6]. Pseudogenes of the mitochondrial ribosomal protein family generally originate from retrotransposition events and do not participate in cellular translation or mitochondrial biogenesis, distinguishing them from their functional counterparts, the **mitochondrial ribosomal proteins (MRPs)**, which are key components of mitochondrial ribosomes critical for oxidative phosphorylation and mitochondrial gene expression[5][7]. Unlike functional MRPs, MRPS36P5 has no recognized molecular or disease roles and carries no associated interacting drugs or known biomarker status. In summary, **MRPS36P5** is a gene fragment classified as a pseudogene related to mitochondrial ribosomal proteins, with no protein product, no established biological role, and no relevance as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein S36 pseudogene 5 (MRPS36P5).